Sunshine Biopharma Receives Health Canada Approval for Generic Ondansetron to Treat Chemotherapy-Induced Nausea

MT Newswires Live
07/28

Sunshine Biopharma (SBFM) said Tuesday that Health Canada has approved its generic Ondansetron tablets of 4 milligrams and 8 milligrams for the Canadian market.

Ondansetron is intended to treat nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery, the company said, adding that it works by blocking the actions of chemicals in the body that trigger nausea and vomiting.

Shares of Sunshine Biopharma were up 2.6% pre-bell.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10